What is Leap Technology?
Leap Technology, operating through its specialized CHRONECT division, provides sophisticated precision lab automation solutions designed to bridge the gap between raw sample collection and final data analysis. The company serves a diverse array of high-stakes industries, including pharmaceutical development, food safety compliance, environmental monitoring, and clinical diagnostics. At the core of its value proposition is the CHRONOS software ecosystem, which integrates seamlessly with modular automated workstations to eliminate human variability and enhance throughput. By offering a comprehensive suite of application consulting and technical support, Leap Technology ensures that its clients maintain rigorous compliance with evolving regulatory standards while maximizing the efficiency of their analytical workflows.
How much funding has Leap Technology raised?
Leap Technology has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Leap Technology
PPP
Public-Private Partnership
What's next for Leap Technology?
With the infusion of this latest capital, Leap Technology is expected to prioritize the scaling of its modular automation platforms to meet the increasing demand for high-throughput testing environments. The strategic focus will likely shift toward expanding its software-as-a-service capabilities within the CHRONOS platform, enabling deeper integration with laboratory information management systems. Furthermore, the company is poised to enhance its global service infrastructure, ensuring that its technical support and application consulting arms can keep pace with its growing international client base. As the industry moves toward greater digitization and automated compliance, Leap Technology remains a pivotal player in defining the future of laboratory efficiency and analytical precision.
See full Leap Technology company page
